Sie sind auf Seite 1von 4

This week we are launching Wikivoyage.

Join us in creating a free travel guide that anyone can edit.




Plasma frozen within 24 hours
From Wikipedia, the free encyclopedia
(Redirected from PF24)
Jump to: navigation, search
Plasma frozen within 24 hours after phlebotomy, commonly called FP24,
[1]
PF-24, or
similar names, is a frozen human blood plasma product used in transfusion medicine. It
differs from fresh-frozen plasma (FFP) in that it is frozen within 24 hours of blood collection,
whereas FFP is frozen within 8 hours. The phrase "FFP" is sometimes used to refer to any
frozen blood plasma product intended for transfusion.
PF24 is stored, thawed, and infused with the same procedures used for FFP. Although it is
technically a different product, most healthcare providers continue to refer to FFP when the
actual component is PF24.
History
The production of PF24 began in response to an increase in reported cases of transfusion-
related acute lung injury, or TRALI. The proposed mechanism of TRALI involves antibodies
from donor blood components (predominantly plasma) that are directed against human
leukocyte antigens (HLA).
[2]
These antibodies are most numerous in women who have been
pregnant more than once. Thus, removing these women from the donor pool for frozen
plasma was proposed as a solution to the TRALI problem (the womens plasma could still be
used for production of other components, including cryoprecipitate). However, removing
roughly half of the donor pool was not a viable alternative, given the increasing need for
plasma transfusion.
The PF24 approach was pioneered in the United Kingdom beginning in 2004
[3]
and in the
United States beginning in 2007.
[4]
The use of PF24 has been accompanied by a decrease in
the incidence of TRALI a roughly 50% reduction in reported cases.
[3]
Long-term studies
on the effectiveness of PF24 in massive transfusion have not been conducted.
This does not address the question of risk from plasma in other components, particularly
apheresis platelets. Removing multiparous women from this limited donor pool would likely
cause too great a shortage of platelets, resulting in more deaths (due to hemorrhage) than are
seen due to TRALI after platelet infusion.

PF24 has roughly 70% of the blood coagulation-factor activity of FFP. Given the fact that
there is typically an overabundance of coagulation factors in normal plasma, the decrease
noted in PF24 is not thought to be clinically significant.

Production
Much of the donor blood supply is obtained at remote blood donation events, such as blood
drives at colleges, community events, etc., rather than at dedicated donation centers. The time
required for transportation and processing often precludes production of FFP in such cases;
that is the plasma cannot be separated and frozen within 8 hours of collection. However, the
(male) donor blood can be separated into packed red blood cells and plasma within 24 hours
(and usually less).
References
1. ^ Yazer MH, Triulzi DJ, Hassett AC, Kiss JE (May 2010). "Cryoprecipitate prepared
from plasma frozen within 24 hours after phlebotomy contains acceptable levels of
fibrinogen and VIIIC". Transfusion 50 (5): 10148. doi:10.1111/j.1537-
2995.2009.02535.x. PMID 20003046.
2. ^ Transfusion-Related Lung Injury (TRALI). Karp, Julie Katz. NewsPath (College of
American Pathologists online newsletter). Posted Jan. 1, 2010.
3. ^
a

b
Mostly male plasma sends TRALI rates south. Paxton, A. CAP Today (lead
article). College of American Pathologists. October 2009.
4. ^ American Association of Blood Banks, Association Bulletin 06-07, November
2006.
[show]
v
t
e
Transfusion medicine
[show]
v
t
e
Routes of administration > Intravenous therapy
View page ratings
Rate this page
What's this?
Trustworthy
Objective
Complete
Well-written
I am highly knowledgeable about this topic (optional)
Categories:
Blood products
Navigation menu
Create account
Log in
Article
Talk
Read
Edit
View history

Main page
Contents
Featured content
Current events
Random article
Donate to Wikipedia
Interaction
Help
About Wikipedia
Community portal
Recent changes
Contact Wikipedia
Toolbox
Print/export
This page was last modified on 19 July 2012 at 17:40.
Text is available under the Creative Commons Attribution-ShareAlike License;
additional terms may apply. See Terms of Use for details.
Wikipedia is a registered trademark of the Wikimedia Foundation, Inc., a non-profit
organization.
Contact us
Privacy policy
About Wikipedia
Disclaimers
Mobile view

Das könnte Ihnen auch gefallen